Policy Recommendations to Promote Prescription Drug Competition: A Position Paper From the American College of Physicians

Hilary Daniel, Josh Serchen, Thomas G. Cooney

Research output: Contribution to journalArticlepeer-review

Abstract

The prescription drug market in the United States relies on competition to keep prices reasonable. Although many policies have been implemented to spur competition and decrease costs for patients, these policies may be outdated and should be redesigned and updated to achieve success in the current prescription drug market. In this paper, the American College of Physicians (ACP) proposes that new policies should be implemented to prevent market manipulation, help lower-cost alternatives make it to the market faster, and ensure a robust and competitive market for generic and biosimilar drugs. The ACP believes these changes will have a meaningful effect on patients without shifting costs to other areas of the health care system.

Original languageEnglish (US)
Pages (from-to)1002-1003
Number of pages2
JournalAnnals of internal medicine
Volume173
Issue number12
DOIs
StatePublished - Dec 15 2020

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Policy Recommendations to Promote Prescription Drug Competition: A Position Paper From the American College of Physicians'. Together they form a unique fingerprint.

Cite this